NASDAQ: NEPHNephros Inc Stock Ownership - Who owns Nephros?
Insider buying vs selling
Have Nephros Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Arthur H. Amron | Director | 2024-05-30 | 3,000 | $2.25 | $6.74kBuy |
| Arthur H. Amron | Director | 2024-05-28 | 2,000 | $2.22 | $4.44kBuy |
| Robert R. Banks Jr. | President and CEO | 2024-05-16 | 50,000 | $2.24 | $112.05kBuy |
NEPH insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NEPH insiders and whales buy or sell their stock.
NEPH Shareholders
What type of owners hold Nephros Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Lambda Investors LLC | 418.59% | 44,372,491 | $88.26M | Insider |
| Wexford Capital LP | 169.64% | 17,982,173 | $35.77M | Insider |
| Stagg Capital Group LLC | 35.37% | 3,749,558 | $7.46M | Insider |
| Wexford Capital LP | 33.97% | 3,600,552 | $7.16M | Institution |
| Enso Capital Management LLC | 32.15% | 3,407,616 | $6.78M | Insider |
| Matthew Rosenberg | 8.00% | 847,935 | $1.69M | Insider |
| Eric A. Md Rose | 5.19% | 550,000 | $1.09M | Insider |
| Southpaw Asset Management LP | 4.95% | 525,079 | $1.04M | Insider |
| Topline Capital Management LLC | 3.96% | 419,887 | $835.16k | Institution |
| Lawrence J. Centella | 2.06% | 218,467 | $434.53k | Insider |
NEPH vs Medical Stocks
Nephros Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.